Infinity Pharma (INFI) Posts Q3 Loss of 36c, Beats Eatimates by 8c

November 9, 2009 4:36 PM EST

Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) reports Q3 loss of $0.36, 8 cents better than the analyst estimate of ($0.44). Revenue for the quarter was $13.8 million, which compares to the estimate of $12.41 million.


Related Categories

Earnings

Stocks Mentioned

INFI 5.95

-0.30 -4.80%
Volume: 28,094
Track INFI


Add Your Comment